I have been working on medical AI, in some form or other, for most of my adult life. For the past 12 months I have taken the opportunity to pause from racing forwards with my own start-ups and to look again, partly as a researcher, at the tools at my disposal and their intended applications. What I have seen worries me.
Part of my efforts to improve things, have taken the form of a number of peer-reviewed scientific articles. A few more such articles are still under review or exist only as work-in-progress. Today I want to summarise the 5 greatest problems which I see facing medical AI systems. For some of them I think that there are clear mitigations. For others, I suspect that we will need to rethink the entire system.
Continue reading “5 Big Challenges Facing Medical AI”
I am asked quite often how I see Data Science in the biomedical industry. I have, of course, many answers each of which is context dependent. However one theme which I find frequently recurring is a sort of straw-man debate which seems to inherently attract technical practitioners.
The debate is usually structured as follows:
Continue reading “Data Science in Biomedical Industry”
How do you see the validation of medical AI products working in practice?
Answer: clinical trials, test-validation sets, blah, blah
But doesn’t this lead to enormous overheads?
Answer: yes, but there are shortcuts
But if you take these shortcuts then don’t you run the risk of running into costly failures when you finally run the clinical trials?
It goes on….
How do I really feel about this topic? I think that I can only work out the answer to this question by writing about it.
My suspicion is that those who shout loudest about personalised medicine know least about it. I fear that the promises being made publicly are categorically not possible. My hope is that I am wrong on this.
Continue reading “Personalised Medicine – A statistical theory approach”